HomeSGX-LISTED COMPANIESChuan Hup Holdings Full Year 2025 Financial Report

Chuan Hup Holdings Full Year 2025 Financial Report

Published on

spot_img

Chuan Hup Holdings Limited experienced a robust FY2025, marked by a significant increase in revenue and net profit, reflecting a stronger overall financial health compared to the previous year.

• Revenue Growth Drivers: Learn about the main contributors to the Group’s boosted revenue

• Enhanced Profitability: Explore the factors behind the substantial rise in net profit, including investment gains and the absence of a one-off expense

• Evolving Asset Base: Understand how new investment properties, particularly in student accommodation, shaped the Group’s asset growth

LISTEN TO THE PODCAST BELOW:

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

More like this

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...